Mannatech appoints James Clavijo as CFO (NASDAQ:MTEX)

Mannatech (NASDAQ:MTEX) announced that it has appointed James Clavijo as Chief Financial Officer, effective July 1.
Clavijo has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron, Guided Therapeutics, Aeterna Zentaris, and Tri-source Pharma.
MTEX +3.092% after hours to $7.0.
Source: Press Release

Previous Post: Alvotech issues new shares to holders of convertible bonds

Next Post: Silvergate Capital and execs charged by SEC for “negligence-based fraud”